Post-transplant diabetic ketoacidosis - A possible consequence of immunosuppression with calcineurin inhibiting agents: A case series

Transplant International

Volumn 13, Issue 1, 2000, Pages 69-72

  Yoshida, Eric M ^a,b   Buczkowski, Andrzej K ^c   Sirrs, Sandra M ^b   Elliott, Tom G ^b   Scudamore, Charles H ^c   Levin, Adeera ^b   Tildesley, Hugh D ^b   Landsberg, David N ^b  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cyclosporine; Diabetes mellitus; Ketoacidosis; Kidney transplantation; Tacrolimus

Indexed keywords

CALCINEURIN; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; ESTERASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE SEVERITY; DRUG BLOOD LEVEL; EMBRYO; FATTY ACID METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN RESISTANCE; KETOACIDOSIS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; METABOLIC ACIDOSIS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0034097915     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb01039.x     Document Type: Article

References (25)

1. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE (1994) GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Diabetes 43: 741-745
2. Bending JJ, Ogg CS, Viberti GC (1987) Diabetogenic effect of cyclosporin. Br Med J 294: 401-402
3. Boudreaux JP, McHugh L, Canafax DM, Asher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS (1987) Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus. Transplant Proc 19: 1811-1813
4. Esmatjes E, Ricart MJ, Ferrer JP, Oppenhaimer F, Vilardell J, Casamitjana R (1991) Cyclosporine's effect on insulin secretion in patients with kidney transplants. Transplantation 52: 500-503
5. European FK506 Multicentre Liver Study Group (1994) Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 344: 423-428
6. Fang J, Huang C, Chuang C, Chu S (1998) Diabetes melllitus after renal transplantation. Transplant Proc 30: 3027-3028
7. Kanzler S, Lohse AW, Schirmacher P, Hermann E, Otto G, Meyer zum Bushcenfelde KH (1996) Complete reversal of FK506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporin A. Z Gastroenterol 34: 128-131
8. Loertscher R, Parfrey PS, Guttman RD (1989) Post-operative management of renal transplant recepients and long-term complications. In: Milford EL, Brenner BM, Stein JH (eds) Renal Transplantation. Churchhill Livingstone, New York, pp 219-220
9. Miles AM, Sumrani N, Horowitz R, Homel P, Maursky V, Markell MS, Distant DA, Hong JH, Sommer BG, Friedman EA (1998) Diabetes mellitus after renal transplantation. Transplantation 65: 380-384
10. Nielsen JH, Mandrup-Poulsen T, Nerup J (1986) Direct effects of cyclosporin A on human pancreatic beta cells. Diabetes 35: 1049-1052
11. Onwubalili JK, Obineche EN (1992) High incidence of post-transplant diabetes mellitus in a single-centre study. Nephrol Dial Transplant 7: 346-349
12. Ost L, Tyden G, Fehrman I (1988) Impaired glucose tolerance in cyclosporinprednisilone-treated renal graft recipients. Transplantation 46: 370-372
13. Rilo HLR, Zeng Y, Alejandro R, Carroll PB, Bereiter D, Venkataramanan R, et al (1991) Effect of FK506 on function of human islets of Langerhans. Transplant Proc 23: 3164-3165
14. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J (1989) Post-transplant hyperglycemia. Transplantation 47: 278-281
15. Scantlebury V, Shapiro R, Fung J, Tsakis A, McCauley J, Jordan M, Jensen C, Hakala T, Simmons R, Starzl TE (1991) New onset diabetes in FK506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 23: 3169-3170
16. Sumrani N, Delaney V, Ding Z, Davis R, Daskalakis P, Friedman EA, Butt KM, Hong JH (1991 ) Posttransplant diabetes mellitus in cyclosporin-treated renal transplant recipients. Transplant Proc 23: 1249-1250
17. Tabasco-Minguillan J, Carroll P, Gavaler J, Van Thiel DH, Starzl TE (1993) Insulin requirements after liver transplantation and FK506 immunosuppression. Transplantation 56: 862-867
18. Tze WJ, Tai J, Cheung S (1990) In vitro effects of FK506 on human and rat islets. Transplantation 49: 1172-1174
19. Tze WJ, Tai J, Murase N, Tzakis A, Starzl TE (1991) Effect of FK506 on glucose metabolism and insulin secretion in noraml rats. Transplant Proc 23: 3158-3160
20. Umpierrez GE, Casals MM, Gebhart SS, Mixon PS, Clark WS, Phillips LS (1995) Diabetic ketoacidosis in obese African-Americans. Diabetes 44: 790-795
21. US Multicenter FK506 Liver Study Group (1994) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110-1115
22. Wagner K, Webber SA, Kurland B, Boyle GJ, Miller SA, Cipriani L, Griffith BP, Fricker FJ (1997) New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. J Heart Lung Transplant 16: 275-282
23. Yagisawa T, Takahashi K, Teraoka S, Toma H, Agishi T, Ota K (1987) Effects of cyclosporin on glucose metabolism in kidney transplant recipients and rats. Transplant Proc 19: 1801-1803
24. Yamamoto H, Akazawa S, Yamaguchi Y, et al (1991) Effects of cyclosporin A and low dosages of steroid on post-transplantation diabetes in kidney transplant recipients. Diabetes Care 14: 867-870
25. Yoshimura N, Nakai I, Ohmori Y, Aikawa I, Fukuda M, Yasumura T, Matsui S, Hamshima T, Oka T (1988) Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 12: 11-17